GlassScriptPhysician profile
Burton Mark Waxman
NPI 1598789216
$351.43
in general payments reported to CMS, 2019-2025
4 companies · $116 in 2025
The $116 reported for 2025 was more than what a typical Endodontics provider received nationally (typical 2025 total: $58.83).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.60 · 2020: $72.93 · 2021: $12.27 · 2022: $50.41 · 2023: $23.29 · 2024: $59.10 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $139 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $58.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $139.39 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $58.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Septodont INC. | $182.17 | 2020-2025 | Bioroot Flow Sample |
| Dentsply Sirona INC | $139.39 | 2023-2025 | Q-Mix, X-Smart, Smartlite Focus |
| Sonendo INC | $17.60 | 2019 | |
| J. Morita USA, INC. | $12.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Burton Waxman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.